Preview

Российский кардиологический журнал

Расширенный поиск

ПАТОЛОГИЯ ГРУДНОГО ОТДЕЛА АОРТЫ ПРИ ДИСПЛАЗИИ СОЕДИНИТЕЛЬНОЙ ТКАНИ

https://doi.org/10.15829/1560-4071-2018-2-80-90

Полный текст:

Аннотация

В статье рассмотрены различные аспекты патологии аорты при дисплазии соединительной ткани, обсуждены подходы диагностики и лечения расширения аорты при данном состоянии.

Об авторах

Г. И. Нечаева
ФГБОУ ВО Омский государственный медицинский университет Минздрава России
Россия

Нечаева Галина Ивановна — доктор медицинских наук, профессор, зав. кафедрой внутренних болезней и семейной медицины



Е. В. Семенова
ФГБОУ ВО Омский государственный медицинский университет Минздрава России
Россия

Семенова Елена Владимировна — соискатель кафедры внутренних болезней и семейной медицины ДПО, врач клиники



А. А. Семенкин
ФГБОУ ВО Омский государственный медицинский университет Минздрава России
Россия

Семенкин Александр Анатольевич — доктор медицинских наук, профессор кафедры внутренних болезней и семейной медицины



И. В. Друк
ФГБОУ ВО Омский государственный медицинский университет Минздрава России
Россия

Друк Инна Викторовна — доктор медицинских наук, профессор кафедры внутренних болезней и семейной медицины



В. П. Конев
ФГБОУ ВО Омский государственный медицинский университет Минздрава России
Россия

Конев Владимир Павлович — доктор медицинских наук, профессор, зав. кафедрой судебной медицины, правоведения



О. И. Чиндарева
ФГБОУ ВО Омский государственный медицинский университет Минздрава России
Россия

Чиндарева Олеся Игорьевна — ассистент кафедры внутренних болезней и семейной медицины



Л. А. Живилова
ФГБОУ ВО Омский государственный медицинский университет Минздрава России
Россия

Живилова Лилия Анатольевна — кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней



Е. Н. Логинова
ФГБОУ ВО Омский государственный медицинский университет Минздрава России
Россия

Логинова Екатерина Николаевна — кандидат медицинских наук, доцент кафедры внутренних болезней и семейной медицины



Т. В. Ткаченко
ФГБОУ ВО Омский государственный медицинский университет Минздрава России
Россия
Ткаченко Татьяна Владимировна — кандидат медицинских наук, доцент кафедры внутренних болезней и семейной медицины


Список литературы

1. Hiratzka LF, Bakris GL, Beckman JA, et al. Guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the ACCF/AHA/AATS/ACR/ASA/SCA/ SCAI/SIR/STS/SVM. Circulation 2010;121:266–369Hiratzka LF, Bakris GL, Beckman JA, et al. Guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM. Circulation 2010; 121: 266-369. DOI: 10.1161/CIR.0b013e3181d47d48.

2. Erbel R, Aboyans V, Boileau C, et al. 2014 Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the ESC, Eur Heart J. 2014; 1; 35 (41): 2873-926. DOI: 10.1093/eurheartj/ehu281.

3. Arias E, Smith BL. Deaths: Preliminary Data for 2001. National Vital Statistics Reports 2003; 5 (51): 1-45.

4. Ramanath VS, Oh JK, Sundt TM 3rd, et al. Acute aortic syndromes and thoracic aortic aneurysm. Mayo Clinic Proceedings. Elsevier 2009; 84 (5): 465-481. DOI: 10.1016/ S0025-6196(11)60566-1.

5. LeMaire SA, Russell L. Epidemiology of thoracic aortic dissection. Nat Rev Cardiol 2011; 8 (2): 103-13. DOI: 10.1038/nrcardio.2010.187.

6. Schoenhoff F, Schmidli J, Czerny M, et al. Management of aortic aneurysms in patients with connective tissue disease. J Cardiovasc Surg 2013; 54 (1): 125-34. ISSN 0021-9509.

7. Sampson UK, Norman PE, Fowkes FG, et al. Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010. Glob Heart. 2014; 9 (1):171-180. DOI: 10.1016/j.gheart.2013.12.010.

8. Milewicz DM, Carlson AA, Regalado ES. Genes Predisposing to Thoracic Aortic Aneurysms and Dissections: Associated Phenotypes, Gene-Specific Management, and Genetic Testing. Cardiol. Clin 2010; 28 (2): 191-7. DOI: 10.1016/j.ccl.2010.01.017.

9. Biddinger A, Rocklin M, Coselli J, Milewicz DM, et al. Familial thoracic aortic dilatations and dissections: a case control study. J. Vasc. Surg 1997; 25: 506-11. DOI: 10.1016/ S0741-5214(97)70261-1.

10. Coady MA, Davies RR, Roberts M, et al. Familial patterns of thoracic aortic aneurysms. Arch Surg 1999; 134: 361-7. doi:10.1001/archsurg.134.4.361

11. Martynov AI, Nechaeva GI. National recommendations of the Russian scientific medical society of therapists for the diagnosis, treatment and rehabilitation of patients with dysplasia of connective tissue. Medicinskij vestnik Severnogo Kavkaza 2016; 11 (1): 2-76. (In Russ.) Мартынов А. И., Нечаева Г. И. Национальные рекомендации российского научного медицинского общества терапевтов по диагностике, лечению и реабилитации пациентов с дисплазиями соединительной ткани. Медицинский вестник Северного Кавказа 2016; 11 (1): 2-76. DOI: 10.14300/mnnc.2016.11001.

12. Lebreiro A, Martins E, Cruz C, et al. Marfan syndrome: clinical manifestations, pathophysiology and new outlook on drug therapy. Rev Port Cardiol. 2010; 29: 1021-36. PMID: 20964113.

13. Karkos CD, Prasad V, Mukhopadhyay U, et al. Rupture of the abdominal aorta in patients with Ehlers-Danlos syndrome. Ann. Vasc. Surg 2000; 14 (3): 274-7. PMID: 10796961.

14. Zemtsovskij EV, Malev EG, Berezovskaya GA, et al. Hereditary disorders of connective tissue in cardiology. Diagnosis and treatment: Russian recommendations (I revision). Russian Journal of Cardiology 2013; 99 (1): 32 p. (In Russ.) Земцовский Э. В., Малев Э. Г., Березовская Г. А. и др. Наследственные нарушения соединительной ткани в кардиологии. Диагностика и лечение: Российские рекомендации (I пересмотр). Российский кардиологический журнал 2013; 99 (1): 32 с.

15. Pomianowski P, Elefteriades JA. The genetics and genomics of thoracic aortic disease. Ann Cardiothorac Surg 2013; 2 (3): 271-79. DOI: 10.3978/j.issn.2225-319X.2013.05.12.

16. Baumgartner H, Bonhoeffer P, De Groot NM, et al. ESC Guidelines for the management of grown-up congenital heart disease. European Heart Journal 2010; 31: 2915-57. DOI:10.1093/eurheartj/ehq249.

17. Détaint D, Faivre L. Cardiovascular manifestations in men and women carrying a FBN1 mutation. Eur Heart J 2010; 31 (18): 2223-9. DOI:10.1093/eurheartj/ehq187.

18. Pyeritz RE. The Marfan syndrome. Annu Rev Med 2000; 51: 481-510. DOI:10.1146/annurev.med.51.1.481.

19. Pearson G, Devereux R, Loeys B, et al. Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on Research in Marfan Syndrome and Related Disorders. Circulation 2008; 118: 785-91. DOI: 10.1161/CIRCULATIONAHA.108.783753.

20. Januzzi JL, Isselbacher EM, Fattori R, et al. Characterizing the Young Patient With Aortic Dissection: Results From the International Registry of Aortic Dissection Journal of the American College of Cardiology 2004; 43 (4): 665-9. DOI: 10.1016/j.jacc.2003.08.054.

21. Milewicz DM, Østergaard JR, Ala-Kokko LM, et al. De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet A. 2010; 152A: 2437-43. DOI: 10.1002/ajmg.a.33657.

22. Rudoy AS. Aortopathy with inherited connective tissue disorders. Supranational (international) recommendations. Minsk; 2016, p. 108. (In Russ.) Рудой А. С. Аортопатии при наследуемых нарушениях соединительной ткани Наднациональные (международные) рекомендации. Минск; 2016, с 108. ISBN 978-985-90384-6-4.

23. Milewicz DM, Regalado E. Heritable Thoracic Aortic Disease Overview. GeneReviews. https://www.ncbi.nlm.nih.gov/books/NBK1120/ (10 December 17).

24. Sutherland A, Escano J, Coon TP. D-dimer as the sole screening test for acute aortic dissection: a review of the literature. Ann Emerg Med 2008; 52: 339-43. DOI: 10.1016/j.annemergmed.2007.12.026.

25. Mensink KA, Ketterling RP, Flynn HC, et al. Connective tissue dysplasia in five new patients with NF1 microdeletions: further expansion of phenotype and review of the literature. J. Med. Genet. 2006; 43 (2): 8. DOI: 10.1136/jmg.2005.034256.

26. Glesby MJ, Pyentz RE. Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum. J. Amer.Med.Ass.1989; 262 (4): 523-8. DOI: 10.1001/jama.1989.03430040095032.

27. Klemenov AV. Undifferentiated connective tissue dysplasia: clinical manifestations, diagnostic capabilities and pathogenetic treatment. M. 2005, p 136. (In Russ) Клеменов А. В. Недифференцированная дисплазия соединительной ткани: клинические проявления, возможности диагностики и патогенетического лечении. М. 2005, с 136.

28. Druk IV, Nechaeva GI, Lyalyukova EA, et al. Cardiovascular syndromes of connective tissue dysplasia in young people: frequency of registration, factors of formation. Lechashchij vrach, 2014; 6: 72. (In Russ.) Друк И. В., Нечаева Г. И., Лялюкова Е. А., и др. Кардиоваскулярные синдромы дисплазии соединительной ткани у лиц молодого возраста: частота регистрации, факторы формирования. Лечащий врач 2014; 6: 72.

29. Brandt T, Morcher M, Hausser I. Association of cervical artery dissection with connective tissue abnormalities in skin and arteries. Front. Neurol. Neurosci. 2005; 20: 16-29. DOI: 10.1159/000088131.

30. Gdynia HJ, Kuhnlein P, Ludolph AC, et al. Connective tissue disorders in dissections of the carotid or vertebral arteries. J. Clin. Neurosci. 2008; 15 (5): 489-94.

31. Morris SA, Orbach DB, Geva T, et al. Increased vertebral artery tortuosity index is associated with adverse outcomes in children and young adults with connective tissue disorders. Circulation 2011; 124 (3): 388-96. DOI: 10.1161/CIRCULATIONAHA.110.990549.

32. Adam MP, Hennekam RCM, Keppen LD, et al. Marshall-Smith syndrome: natural history and evidence of an osteochondrodysplasia with connective tissue abnormalities. Am. J. Med. Genet. A. 2005; 137 (2): 117-24. DOI: 10.1002/ajmg.a.30580.

33. Lammers K, Lince SL, Spath MA, et al. Pelvic organ prolapse and collagen-associated disorders. Int Urogynecol J. 2012; 23 (3): 313-9. DOI: 10.1007/s00192-011-1532-y.

34. Kirschner J, Hausser I, Zou Y, et al. Ullrich congenital muscular dystrophy: connective tissue abnormalities in the skin support overlap with Ehlers-Danlos syndromes. Am. J. Med. Genet. A. 2005; 132 (3): 296-301. DOI: 10.1002/ajmg.a.30443.

35. Nechaeva GI, Konev VP, Druk IV. Detection and management tactics of patients with undifferentiated connective tissue dysplasia: method. recommendations for doctors. M.: WP PRE100. 2011, p 52. (In Russ.) Нечаева, Г. И., Конев В. П., Друк И. В. Выявление и тактика ведения пациентов с недифференцированной дисплазией соединительной ткани: метод. рекомендации для врачей. М.: РГ ПРЕ100. 2011, c 52.

36. Rhee D, Solowiejczyk D. Incidence of Aortic Root Dilatation in Pectus Excavatum and Its Association With Marfan Syndrome. Arch Pediatr Adolesc Med. 2008; 162 (9): 882-85. DOI: 10.1001/archpedi.162.9.882.

37. Gaidar BV, Parfenov VE, Svistov DV. Evaluation of reactivity of cerebral blood flow using ultrasound diagnostic methods. Ultrasonic dopplerographic diagnosis of vascular diseases. Moscow, 1998: 241-8. (In Russ.) Гайдар Б. В., Парфенов В. Е., Свистов Д. В. Оценка реактивности мозгового кровотока с применением ультразвуковых методов диагностики. Ультразвуковая допплерографическая диагностика сосудистых заболеваний. Москва, 1998: 241-8.

38. Viktorova IA, Nechaeva GI, Konev VP, et al. Clinical prognostic criteria for connective tissue dysplasia. Rossijskie medicinskie vesti 2009; 14 (1): 102-11. (In Russ.) Викторова И. А. Нечаева Г. И., Конев В. П. и др. Клинико-прогностические критерии дисплазии соединительной ткани. Рос. мед. вести 2009; 14 (1): 102-11.

39. Smith K, Kalko S, Cantor C. Pulse-electrophoresis and methods of working with large DNA molecules. Analysis of the genome. M: World, 1990: 58-94. (In Russ.) Смит К., Калко С., Кантор Ч. Пульс-электрофорез и методы работы с большими молекулами ДНК. Анализ генома. М: Мир, 1990: 58-94.

40. Sherrah AG, Andvik S, van der Linde D, et al. Nonsyndromic Thoracic Aortic Aneurysm and Dissection: Outcomes With Marfan Syndrome Versus Bicuspid Aortic Valve Aneurysm. JACC 2016; 67 (6): 618-26. DOI: 10.1016/j.jacc.2015.11.039.

41. Jones JA, Ikonomidis JS. The Pathogenesis of Aortopathy in Marfan Syndrome and Related Diseases. Curr Cardiol Rep 2010; 12: 99-107. DOI: 10.1007/s11886-0100083-z.

42. Caglayan AO, Dundar M. Inherited diseases and syndromes leading to aortic aneurysms and dissections European Journal of Cardio-thoracic Surgery 2009; 35: 931-40. DOI: 10.1016/j.ejcts.2009.01.006.

43. Hutchinson S, Furger A, Halliday D, et al. Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype? Hum Mol Genet 2003; 12: 2269-76. DOI: 10.1093/hmg/ddg241.

44. Booms P, Cisler J, Mathews KR, et al. Novel exon skipping mutation in the fibrillin-1 gene: two ‘hot spots’ for the neonatal Marfan syndrome. Clin Genet 1999; 55: 110-7. DOI: 10.1034/j.1399-0004.1999.550207.x.

45. Hayward C, Porteous ME, Brock DJ. A novel mutation in the fibrillin gene (FBN1) in familial arachnodactyly. Mol Cell Probes 1994; 8: 325-7. DOI: 10.1006/mcpr.1994.1045.

46. Lonnqvist L, Child A, Kainulainen K, et al. A novel mutation of the fibrillin gene causing ectopia lentis. Genomics 1994; 19: 573-6. DOI: 10.1006/geno.1994.1110.

47. Francke U, Berg M. A., Tynan K, et al. Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. Am J Hum Genet 1995; 56: 1287-96. PMCID: PMC1801106.

48. Milewicz DM, Michael K, Fisher N, et al. Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation 1996; 94: 2708-11. DOI: 10.1161/01.CIR.94.11.2708.

49. Dietz HC, McIntosh I, Sakai LY, et al. Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome. Genomics 1993; 17: 468-75. DOI: 10.1006/geno.1993.1349.

50. Stahl-Hallengren C, Ukkonen T, Kainulainen K, et al. An extra cysteine in one of the noncalciumbinding epidermal growth factor-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome. J Clin Invest 1994; 94: 709-13. DOI: 10.1172/JCI117389.

51. Black C, Withers AP, Gray JR, et al. Correlation of a recurrent FBN1 mutation (R122C) with an atypical familial Marfan syndrome phenotype. Hum Mutat 1998; (Suppl.): S198-200. PMID: 9452085.

52. Milewicz DM, Grossfield J, Cao SN, et al. A mutation in FBN1 disrupts profibrillin processing and results in isolated skeletal features of the Marfan syndrome. J Clin Invest 1995; 95: 2373-8. DOI: 10.1172/JCI117930.

53. Nechaeva GI, Martynov AI. Dysplasia of connective tissue: cardiovascular changes, modern approaches to diagnosis and treatment. Moscow: Medical Informational Agency Publishing House. 2017; p. 400. (In Russ.) Нечаева Г. И., Мартынов А. И. Дисплазия соединительной ткани: сердечно-сосудистые изменения, современные подходы к диагностике и лечению. Москва: ООО “Издательство “Медицинское информационное агентство”. 2017; c 400.

54. Konev VP. The main morphological phenomena for sectional diagnosis of connective tissue dysplasia. Siberian Medical Journal 2011; 26 (3-2): 19-22. (In Russ.) Конев В. П. Основные морфологические феномены для секционной диагностики дисплазии соединительной ткани. Сибирский медицинский журнал 2011; 26 (3-2): 19-22.

55. Collins MJ, Dev V, Strauss BH, et al. Variation in the histopathological features of patients with ascending aortic aneurysms: a study of 111 surgically excised cases J Clin Pathol 2008; 61: 519-23. DOI: 10.1136/jcp.2006.046250.

56. Shilova MA, Konev VP, Tsaregorodtsev AG. Vascular pathology in individuals with connective tissue dysplasia in the aspect of sudden death. Kazan. honey. journal. 2007; 88 (5): 33-5. (Шилова М. А., Конев В. П., Царегородцев А. Г. Патология сосудов у лиц с дисплазией соединительной ткани в аспекте внезапной смерти. Казан. мед. журн. 2007; 88 (5): 33-5.

57. Savunen T, Aho HJ. Annulo-aortic ectasia. Light and electron microscopic changes in aortic media. Virchows Arch. A Pathol. Anat. Histopathol 1985; 407: 279-88.

58. Lawrie GM, Earle N, DeBakey ME. Long-term fate of the aortic root and aortic valve after ascending aneurysm surgery. Ann Surg 1993; 217: 711-0. PMCID: PMC1242883.

59. Crawford ES, Svensson LG, Coselli JS, et al. Surgical treatment of aneurysm and/ or dissection of the ascending aorta, transverse aortic arch, and ascending aorta and transverse aortic arch. Factors influencing survival in 717 patients. J Thorac Cardiovasc Surg 1989; 98: 659-73. PMID: 2811404.

60. Pepin M, Schwarze U, Superti-Furga A, et al. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000; 342: 673-80. DOI: 10.1056/NEJM200003093421001.

61. De Paepe A, Malfait F. Bleeding and bruising in individuals with Ehlers-Danlos syndrome and other collagen vascular disorders. Br J Haematol 2004; 127: 491-500. DOI: 10.1111/j.1365-2141.2004.05220.x.

62. Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management and clinical outcome of Ehlers—Danlos syndrome type IV: a 30-year experience. J Vasc Surg 2005; 42: 98-106. DOI: 10.1016/j.jvs.2005.03.053.

63. Loeys BL, Dietz HC, Braverman AC, et al. The revised Ghent nosology for the Marfan syndrome J Med Genet 2010; 47: 476-85. DOI: 10.1136/jmg.2009.072785.

64. Aburawi EH, O’Sullivan J. Relation of aortic root dilatation and age in Marfan’s syndrome. European Heart Journal. 2007; 28: 376-9. DOI: 10.1093/eurheartj/ehl457.

65. Nechaeva GI, Viktorova IA. Dysplasia of connective tissue: terminology, diagnosis, tactics of patients management. Omsk, OOO “Typografiya BLANKOM”, 2007; 188 p. (In Russ.) Нечаева Г. И., Викторова И. А. Дисплазия соединительной ткани: терминология, диагностика, тактика ведения пациентов. Омск, ООО “Типография БЛАНКОМ”, 2007; с.188.

66. Klompas M. Does this patient have an acute thoracic aortic dissection? JAMA. 2002; 287: 2262-72. DOI: 10.1001/jama.287.17.2262.

67. Erbel R, Engberding R, Daniel W, et al. Echocardiography in diagnosis of aortic dissection. Lancet. 1989; 1: 457-61. DOI: 10.1016/S0140-6736(89)91364-0.

68. Umana JP, Miller DC, Mitchell RS. What is the best treatment for patients with acute type B aortic dissections: medical, surgical, or endovascular stent-grafting? Ann Thorac Surg. 2002; 74: 1840-3. DOI: 10.1016/S0003-4975(02)04140-1.

69. Shores J, Berger KR, Murphy EA, et al. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med. 1994; 330: 1335-41. DOI: 10.1056/NEJM199405123301902.

70. Sommer T, Fehske W, Holzknecht N, et al. Aortic dissection: a comparative study of diagnosis with spiral CT, multiplanar transesophageal echocardiography, and MR imaging. Radiology. 1996; 199: 347-52. DOI: 10.1148/radiology.199.2.8668776.

71. Francois CJ, Carr JC. MRI of the thoracic aorta. Cardiol Clin. 2007; 25: 171-84.

72. Kapustin AJ, Litt HI. Diagnostic imaging for aortic dissection. Semin Thorac Cardiovasc Surg. 2005; 17: 214-23.

73. Cigarroa JE, Isselbacher EM, DeSanctis RW, et al. Diagnostic imaging in the evaluation of suspected aortic dissection. Old standards and new directions N Engl J Med. 1993; 328: 35-43. DOI: 10.1056/NEJM199301073280107.

74. Tsai TT, Nienaber CA, Eagle KA. Acute aortic syndromes. Circulation. 2005; 112: 3802-13. DOI: 10.1161/CIRCULATIONAHA.105.534198.

75. Miller JS, Lemaire SA, Coselli JS. Evaluating aortic dissection: when is coronary angiography indicated? Heart. 2000; 83: 615-6. DOI: 10.1136/heart.83.6.615.

76. Flachskampf FA, Badano L, Daniel WG, et al. Recommendations for transoesophageal echocardiography: update 2010. Eur J Echocardiogr 2010; 11: 557-76. DOI: 10.1093/ejechocard/jeq057.

77. Evangelista A, Aguilar R, Cuellar H, et al. Usefulness of real-time threedimensional transoesophageal echocardiography in the assessment of chronic aortic dissection. Eur J Echocardiogr 2011; 12: 272-7. DOI: 10.1093/ejechocard/jeq191.

78. Goldstein S. A. Evangelista A, Abbara S, et al. Multimodality Imaging of Diseases of the Thoracic Aorta in Adults: From the American Society of Echocardiography and the European Association of Cardiovascular Imaging Endorsed by the Society of Cardiovascular Computed Tomography and Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2015; 28: 119-82. DOI: 10.1016/j.echo.2014.11.015.

79. Evangelista A, Flachskampf FA, Erbel R. Echocardiography in aortic diseases: EAE recommendations for clinical practice. Eur J Echocardiogr 2010; 11: 645-58. DOI: 10.1093/ejechocard/jeq056.

80. De Backer J, Loeys B, Devos D, et al. A critical analysis of minor cardiovascular criteria in the diagnostic evaluation of patients with Marfan syndrome. Genet Med 2006; 8: 401-8. DOI: 10.1097/01.gim.0000223550.41849.e3.

81. Devereux RB, de Simone G, Arnett DK, et al. Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons >/=15 years of age. Am J Cardiol 2012; 110: 1189-94. DOI: 10.1016/j.amjcard.2012.05.063.

82. Vriz O, Driussi C, Bettio M, et al. Aortic root dimensions and stiffness in healthy subjects. Am J Cardiol 2013; 112: 1224-9. DOI: 10.1016/j.amjcard.2013.05.068.

83. Burman ED, Keegan J, Kilner PJ. Aortic root measurement by cardiovascular magnetic resonance: specification of planes and lines of measurement and corresponding normal values. Circ Cardiovasc Imaging 2008; 1: 104-13. DOI: 10.1161/CIRCIMAGING.108.768911.

84. Hager A, Kaemmerer H, Rapp-Bernhardt U, et al. Diameters of the thoracic aorta throughout life as measured with helical computed tomography. J Thorac Cardiovasc Surg 2002; 123: 1060-6. DOI: 10.1067/mtc.2002.122310.

85. Lin FY, Devereux RB, Roman MJ, et al. Assessment of the thoracic aorta by multidetector computed tomography: ageand sex-specific reference values in adults without evident cardiovascular disease. J Cardiovasc Comput Tomogr 2008; 2: 298-308. DOI: 10.1016/j.jcct.2008.08.002.

86. Roman MJ, Devereux RB, Kramer-Fox R, et al. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 1989; 64: 507-12. DOI: 10.1016/0002-9149(89)90430-X.

87. Vasan RS, Larson MG, Benjamin EJ, et al. Echocardiographic reference values for aortic root size: the Framingham Heart Study. J Am Soc Echocardiogr 1995; 8: 793-800. PMID: 8611279.

88. Wolak A, Gransar H, Thomson LE, et al. Aortic size assessment by noncontrast cardiac computed tomography: normal limits by age, gender, and body surface area. JACC Cardiovasc Imaging 2008; 1: 200-9. DOI: 10.1016/j.jcmg.2007.11.005.

89. Kalsch H, Lehmann N, Mohlenkamp S, et al. Body-surface adjusted aortic reference diameters for improved identification of patients with thoracic aortic aneurysms: results from the population-based Heinz Nixdorf Recall study. Int J Cardiol 2013; 163: 72-8. DOI: 10.1016/j.ijcard.2011.05.039.

90. Lu TL, Huber CH, Rizzo E, et al. Ascending aorta measurements as assessed by ECGgated multi-detector computed tomography: a pilot study to establish normative values for transcatheter therapies. Eur Radiol 2009; 19: 664-9. DOI: 10.1007/s00330-008-1182-8.

91. Mao SS, Ahmadi N, Shah B, et al. Normal thoracic aorta diameter on cardiac computed tomography in healthy asymptomatic adults: impact of age and gender. Acad Radiol 2008; 15: 827-34. DOI: 10.1016/j.acra.2008.02.001.

92. Tsang JF, Lytwyn M, Farag A, et al. Multimodality imaging of aortic dimensions: comparison of transthoracic echocardiography with multidetector row computed tomography. Echocardiography 2012; 29: 735-41. DOI: 10.1111/j.1540-8175.2012.01666.x.

93. Garcier JM, Petitcolin V, Filaire M, et al. Normal diameter of the thoracic aorta in adults: a magnetic resonance imaging study. Surg Radiol Anat 2003; 25:322-9. DOI: 10.1007/s00276-003-0140-z.

94. Muraru D, Maffessanti F, Kocabay G, et al. Ascending aorta diameters measured by echocardiography using both leading edge-to-leading edge and inner edge-to-inner edge conventions in healthy volunteers. Eur Heart J Cardiovasc Imaging 2014; 15: 415-22. DOI: 10.1093/ehjci/jet173.

95. Quint LE, Liu PS, Booher AM, et al. Proximal thoracic aortic diameter measurements at CT: repeatability and reproducibility according to measurement method. Int J Cardiovasc Imaging 2013; 29: 479-88. DOI: 10.1007/s10554-012-0102-9.

96. Campens L, Demulier L, De Groote K, et al. Reference values for echocardiographic assessment of the diameter of the aortic root and ascending aorta spanning all age categories. The American journal of cardiology 2014; 114 (6): 914-20. DOI: 10.1016/j.amjcard.2014.06.024.

97. Dallaire F, Bigras JL, Prsa M, et al. Bias related to body mass index in pediatric echocardiographic Z scores. Pediatr Cardiol. 2015; 36 (3): 667-76. DOI: 10.1007/s00246014-1063-7.

98. Cantinotti M, Scalese M, Murzi B, et al. Echocardiographic nomograms for ventricular, valvular and arterial dimensions in caucasian children with a special focus on neonates, infants and toddlers. J Am Soc Echocardiogr. 2014; 27 (2): 179-91. DOI: 10.1016/j.echo.2013.10.001.

99. Gautier M, Detaint D, Fermanian C, et al. Nomograms for aortic root diameters in children using two-dimensional echocardiography. Am J Cardiol. 2010; 105 (6): 888-94. DOI: 10.1016/j.amjcard.2009.11.040.

100. Rozendaal L, Groenink M, Naeff MS, et al. Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilation. Heart 1998; 78: 69-72. DOI: 10.1136/hrt.79.1.69.

101. Daubeney PE, Blackstone EH, Weintraub RG, et al. Relationship of the dimension of cardiac structures to body size: an echocardiographic study in normal infants and children. Cardiol Young. 1999; 9 (4): 402-10. PMID: 10476831.

102. Zilberman MV, Khoury PR, Kimball RT. Two-dimensional echocardiographic valve measurements in healthy children: gender-specific differences. Pediatr Cardiol. 2005; 26 (4): 356-60. DOI: 10.1007/s00246-004-0736-z.

103. Warren AE, Boyd ML, O’Connell C, et al. Dilatation of the ascending aorta in paediatric patients with bicuspid aortic valve: frequency, rate of progression and risk factors. Heart.2006; 92 (10): 1496-500. DOI: 10.1136/hrt.2005.081539.

104. Pettersen MD, Du W, Skeens ME. et al. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr. 2008; 21 (8): 922-34. DOI: 10.1016/j.echo.2008.02.006.

105. Colan SD, McElhinney DB, Crawford EC, et al. Validation and re-evaluation of a discriminant model predicting anatomic suitability for biventricular repair in neonates with aortic stenosis. J Am Coll Cardiol. 2006; 47 (9): 1858-65. DOI: 10.1016/j.jacc.2006.02.020.

106. Semenova EV, Semenkin AA, Chindareva OI, et al. Optimization of the approach to the determination of aortic root enlargement in undifferentiated connective tissue dysplasia. Cardiology: news, opinions, training 2017; 1 (12): 35-9. (In Russ.) Семенова Е. В. Семенкин А. А., Чиндарева О. И., и др. Оптимизация подхода к определению расширения корня аорты при недифференцированной дисплазии соединительной ткани. Кардиология: новости, мнения, обучение 2017; 1 (12): 35-9.

107. Bruno L, Tredici S, Mangiavacchi M, et al. Cardiac, skeletal, and ocular abnormalities in patients with Marfan’s syndrome and in their relatives Comparison with the cardiac abnormalities in patients with kyphoscoliosis. Br Heart J 1984; 51: 220-30. DOI: 10.1136/hrt.51.2.220.

108. Patent for Invention Method for determining the proper diameter of the root of the aorta No. 2627603, 2017, Russian Federation Semenkin AA, Semenova EV, Chindareva OI, et al. (In Russ.) Патент на изобретение Способ определения должного диаметра корня аорты № 2627603, 2017, Российская Федерация Семенкин А. А., Семенова Е. В., Чиндарева О. И., и др.

109. Lacro RV, Dietz HC, Sleeper LA, et al. Atenolol versus losartan in children and young adults with Marfan’s syndrome. N Engl J Med 2014; 371: 2061-71. DOI: 10.1056/NEJMoa1404731.

110. Milleron O, Arnoult F, Ropers J, et al. Marfan Sartan: a randomized, double-blind, placebocontrolled trial. Eur Heart J 2015; 36: 2160-6. DOI: 10.1093/eurheartj/ehv151.

111. Forteza A, Evangelista A, Sanchez V, et al. Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial. Eur Heart J 2016; 37: 978-85. DOI: 10.1093/eurheartj/ehv575.

112. Mullen MJ, Flather MD. A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol. Trials 2013, 14: 408. DOI: 10.1186/1745-6215-14-408.

113. Baumgartner H, Falk V. ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 2017; 38: 2739-91. DOI: 10.1093/eurheartj/ehx391.

114. Groenink M, de Roos A, Mulder BJ, et al. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol 1988; 82 (2): 203-8. DOI: 10.1016/S00029149(98)00315-4.

115. Haouzi A, Berglund H, Pelikan PC, et al. Heterogeneous aortic response to acute betaadrenergic blockade in Marfan syndrome. Am Heart J 1997; 133 (1): 60-3. DOI:10.1016/S0002-8703(97)70248-5.

116. Mueller GC, Stierle L, Stark V, et al. Retrospective analysis of the effect of angiotensin II receptor blocker versus β-blocker on aortic root growth in paediatric patients with Marfan syndrome. Heart 2014; 100: 214-8. DOI: 10.1136/heartjnl-2013-304946.

117. Silverman DI, Burton KJ, Gray J, et al. Life expectancy in the Marfan syndrome. Am J Cardiol 1995; 75 (2): 157-60. DOI: 10.1016/S0002-9149(00)80066-1.

118. Gersony DR, McClaughlin MA, Jin Z, et al. The effect of beta-blocker therapy on clinical outcome in patients with Marfan’s syndrome: A meta-analysis. Int J Cardiol 2007; 114: 303-8. DOI: 10.1016/j.ijcard.2005.11.116.

119. Thakur V, Rankin KN, Hartling L, et al. A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome. Cardiology in the Young 2013; 23: 568-81. DOI: 10.1017/S1047951112001412.

120. Lu H, Rateri DL, Cassis LA, et al. The role of the renin–angiotensin system in aortic aneurysmal diseases. Curr Hypertens Rep 2008; 10: 99-106. PMCID: PMC2846534. NIHMSID: NIHMS140855.

121. Habashi JP, Judge DP, Holm TM, et al. Losartan, an at1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312: 117-21. DOI: 10.1126/science.1124287.

122. Therrien J, Gatzoulis M, Graham T, et al. Canadian Cardiovascular Society Consensus Conference 2001 update; Recommendations for the Management of Adults with Congenital Heart Disease-Part II. Can J Cardiol 2001; 17: 1029-50. PMID: 11694894.

123. Aalberts JJJ. Marfan syndrome and related connective tissue disorders Cardiological and genetic aspects 2014, 132 p.

124. Aalberts JJJ, Waterbolk TW. Prophylactic aortic root surgery in patients with Marfan syndrome: 10 years’ experience with a protocol based on body surface area Eur J Cardiothorac Surg. 2008; 34: 589-94. ISBN: 978-90-367-6779-8.

125. Kim EK, Choi SH, Sung K. Aortic diameter predicts acute type A aortic dissection in patients with Marfan syndrome but not in patients without Marfan syndrome The Journal of Thoracic and Cardiovascular Surgery 2014; 147 (5): 1505-10. DOI: 10.1016/j.jtcvs.2013.05.025.

126. Erbel R, Alfonso F, Boileau C, et al. Diagnosis and management of aortic dissection. Eur Heart J. 2001; 22: 1642-81. DOI: 10.1053/euhj.2001.2782.

127. Elefteriades JA, Farkas EA. Thoracic aortic aneurysm clinically pertinent controversies and uncertainties. J Am Coll Cardiol. 2010; 55: 841-57. DOI: 10.1016/j.jacc.2009.08.084.

128. Baumgartner H, Bonhoeffer P, De Groot NMS. ESC Guidelines for the management of grown-up congenital heart disease. Heart Journal 2010; 31: 2915-57. DOI: 10.1093/eurheartj/ehq249.

129. Legget ME, Unger TA, et al. Aortic root complications in Marfan’s syndrome: identification of a lower risk group. Heart 1996; 75: 389-95. DOI: 10.1136/hrt.75.4.389.

130. Ágg B, Benke K. Possible extracardiac predictors of aortic dissection in Marfan syndrome BMC Cardiovascular Disorders 2014; 14: 47. DOI: 10.1186/1471-2261-14-47.


Для цитирования:


Нечаева Г.И., Семенова Е.В., Семенкин А.А., Друк И.В., Конев В.П., Чиндарева О.И., Живилова Л.А., Логинова Е.Н., Ткаченко Т.В. ПАТОЛОГИЯ ГРУДНОГО ОТДЕЛА АОРТЫ ПРИ ДИСПЛАЗИИ СОЕДИНИТЕЛЬНОЙ ТКАНИ. Российский кардиологический журнал. 2018;(2):80-90. https://doi.org/10.15829/1560-4071-2018-2-80-90

For citation:


Nechaeva G.I., Semenova E.V., Semenkin A.A., Druk I.V., Konev V.P., Chindareva O.I., Zhivilova L.А., Loginova E.N., Tkachenko T.V. PATHOLOGY OF THORACIC AORTA IN CONNECTIVE TISSUE DYSPLASIAS. Russian Journal of Cardiology. 2018;(2):80-90. (In Russ.) https://doi.org/10.15829/1560-4071-2018-2-80-90

Просмотров: 161


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)